12 резултата
TECHNICAL FIELD
The present invention relates to methods and kits for the treatment of breast cancer based on hormone receptor status of the progesterone receptor and the estrogen receptor comprising the administration of a taxaric alone, in combination with at least one other and other therapeutic
TECHNICAL FIELD
The present invention relates to methods and kits for the treatment of breast cancer based on hormone receptor status of the progesterone receptor and the estrogen receptor comprising the administration of a taxane alone, in combination with at least one other and other therapeutic
TECHNICAL FIELD
The present invention relates to methods and kits for the treatment of breast cancer based on hormone receptor status of the progesterone receptor and the estrogen receptor comprising the administration of a taxane alone, in combination with at least one other and other therapeutic
FIELD OF THE INVENTION
This invention relates to compositions comprising taxanes or taxoids and proteins, such as albumin or transferrin, useful for the treatment of cancers.
BACKGROUND OF THE INVENTION
Taxanes are a family of compounds that includes paclitaxel, a cytotoxic natural product, and
FIELD OF THE INVENTION
The invention is in the field of therapeutic compositions and methods, particularly chemotherapy of cancer using ginsenosides.
BACKGROUND OF THE INVENTION
Panax ginseng has served as an important component of traditional Chinese medicine for thousands of years. Recently,
BACKGROUND
As described in U.S. Pat. Nos. 6,868,289 and 7,016,725 each of which is incorporated herein by reference, and in U.S. patent application Ser. No. 11/111,439 (filed Apr. 21, 2005 and published as US2005/0209642) and Ser. No. 11/537,026 (filed Sep. 29, 2006), each of which is incorporated
FIELD OF THE INVENTION
The present invention relates to a novel compound and pharmaceutical composition thereof for treating mammalian cell proliferative disorders, chemo-therapy resistance and virus infections, particularly a novel .gamma.-butyrolactone compound and pharmaceutical composition
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the field of cancer treatment. More specifically, the present invention relates to the unexpected synergistic effects of nuclear transcription factor NF-.kappa.B inhibitors and anti-neoplastic agents in
TECHNICAL FIELD
The present invention relates to a method of treating cancer by co-administration of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-- 1H-naphtho[2,3-d]imidazol-3-ium bromide and one or more other anticancer agents. The present invention also relates to the
TECHNICAL FIELD
The present invention relates to a method of treating cancer by co-administration of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-- 1H-naphtho[2,3-d]imidazol-3-ium bromide and one or more other anticancer agents. The present invention also relates to the
BACKGROUND OF THE INVENTION
Black cohosh, Actaea racemosa L. (Cimicifuga racemosa), a perennial in the buttercup family (Ranunculaceae), is frequently used to treat gynecological and other conditions. In particular, the roots and rhizomes of black cohosh have been used to treat a variety of
BACKGROUND
Numerous high-grade malignancies and precancerous conditions exist that are difficult to treat, prevent and eradicate. Many of such conditions are affiliated with breast cancer, prostate cancer, skin cancer, oral cancer, and precancerous conditions thereof. Furthermore, current treatment